Evidence of a role for RANKL in the development of myeloma bone disease

• 1 August 2004
• journal article
• review article
• Published by Elsevier in Current Opinion in Pharmacology
• Vol. 4  (4) , 340-346
• https://doi.org/10.1016/j.coph.2004.03.011

Abstract

Keywords

• NF-ΚB
• NUCLEAR FACTOR-ΚB
• ODF
• OSTEOCLAST DIFFERENTIATION FACTOR
• OPG
• OSTEOPROTEGERIN
• OPGL
• OSTEOPROTEGERIN LIGAND
• RANK
• RECEPTOR ACTIVATOR OF NFΚB
• RANKL
• LIGAND FOR RECEPTOR ACTIVATOR OF NFΚB
• TNF
• TUMOUR NECROSIS FACTOR
• TRAIL
• TNF-RELATED APOPTOSIS-INDUCING LIGAND
• TRANCE
• TNF-RELATED ACTIVATION-INDUCED CYTOKINE